Related Experiment Video
Updated: May 11, 2026

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Internet versus in-person counseling for patients taking varenicline for smoking cessation
Kent J Dezee1, Jennifer S Wink, Christopher M Cowan
1Department of Medicine, Uniformed Services University, 4301 Jones Bridge Road, Bethesda, MD 20814, USA.
Introduction:
Quit rates for smoking cessation attempts are maximized by using counseling with medication. Internet-based counseling might be a suitable replacement for in-person counseling.
Methods:
Patients in a military medical system in the active phase of quitting presented for study intake. They were randomized to in-person counseling (n = 44) or Internet counseling (n = 173). In-person counseling consisted of four 1.5 hour classes based on the American Cancer Society's Freshstart program. Internet counseling consisted of daily e-mails with recommended activities through Pfizer's GetQuit program. Both groups were concomitantly treated with standard dose varenicline. The primary outcome was the quit rate at 12 weeks, defined as abstinence and an exhaled carbon monoxide level <10 ppm at the 12-week visit. All those lost to follow-up were considered persistent smokers.
Results:
217 smokers were randomized, of which 43% returned for the 12-week follow-up visit. Quit rates between the two groups were similar (Internet group: 21%, n = 36/173; in-person group: 18%, n = 8/44, p = 0.7).
Conclusions:
Internet-based counseling might be equivalent to in-person counseling for smoking cessation in patients taking varenicline. Additional studies with more complete and longer-term (≥1 year) follow-up are needed to confirm these findings.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
COPD: Management Using Bronchodilators and Corticosteroids
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
